Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). - Wang, Xin; Chen, Zhuo; Tong, Linjiang; Tan, Shaoying; Zhou, Wei; Peng, Ting; Han, Kun; Ding, Jian; Xie, Hua; Xu, Yufang (European Journal of Medicinal Chemistry, 2013)